Enjoy complimentary customisation on priority with our Enterprise License!
The Human Epidermal Growth Factor Receptor 2 Inhibitors Market size is estimated to grow by USD 11.067 billion at a CAGR of 9.94% between 2023 and 2028.
The global human epidermal growth factor receptor 2 (HER2) inhibitors market has been propelled by continual development in R&D efforts. Treatment choices have been greatly increased, and patient outcomes have improved as a result of the discovery of more potent HER2 inhibitors through R&D initiatives. Notably, the landscape of HER2-positive breast and gastric cancer therapy has been revolutionized by more recent monoclonal antibodies and targeted medicines. Moreover, when combined with trastuzumab, the monoclonal antibody pertuzumab has demonstrated improved inhibition of HER2-positive tumor cell proliferation. Additionally, continuing R&D projects concentrate on reducing adverse effects, enhancing drug delivery systems, and investigating novel medication combinations, assuring a constant influx of cutting-edge HER2 inhibitors. Such factors will increase the demand for HER2 inhibitors, thereby driving the growth of the market during the forecast period. It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2018 to 2022, besides analyzing the current market scenario.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.